A Study of Efficacy, Safety, Tolerability of LXE408 in Participants With Chronic Chagas Disease.
A Study of Efficacy, Safety, Tolerability of LXE408 in Participants With Chronic Chagas Disease.
Recruiting · NCT06632600 · Registry updated 2026-09-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Efficacy, Safety, Tolerability of LXE408 in Participants With Chronic Chagas Disease. | Chagas disease, Euglenozoa Infections, Infections, parasitic infectious disease, protozoa infectious disease, trypanosomiasis, vector-borne disease | Recruiting | Phase 2 | 2026-09-15 | NCT06632600 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Novartis Pharmaceuticals | 432 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Baylor College of Medicine | Houston | United States | 2 |
| Boston Medical Center | Boston | United States | 200 |
| Olive View UCLA Educ and Res Ins | Sylmar | United States | 1 |
| University of Florida Shands | Gainesville | United States | 1 |